JUN and neoplasm: Compared with mock-treated T cells, 2xAARE-YB-CAR-Jun-T cells significantly reduced tumor growth, whereas EF1a-CAR-T cells had a less pronounced effect (Fig. 7B), despite similar numbers of CAR-T cells infiltrating the tumors under both conditions (Fig. 7C and Supplementary Fig. 8A).